Jove
Visualize
联系我们
JoVE
x logofacebook logolinkedin logoyoutube logo
关于 JoVE
概览领导团队博客JoVE 帮助中心
作者
出版流程编辑委员会范围与政策同行评审常见问题投稿
图书馆员
用户评价订阅访问资源图书馆顾问委员会常见问题
研究
JoVE JournalMethods CollectionsJoVE Encyclopedia of Experiments存档
教育
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab Manual教师资源中心教师网站
使用条款与条件
隐私政策
政策

相关概念视频

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs01:25

Antiasthma Drugs: Mast Cell Stabilizers and Anti-IgE Drugs

1.7K
Asthma is a chronic respiratory condition for which new therapeutic avenues, including anti-inflammatory drugs like mast cell stabilizers and anti-IgE treatments, continue to be developed.
Mast cell stabilizers, such as cromolyn (also known as sodium cromoglycate) and nedocromil (Tilade), are effective drugs in asthma management. These stabilizers hinder histamine release by skillfully obstructing the activation of mast cells and other cellular entities. Notably, they navigate this task without...
1.7K
Tumor Immunotherapy01:27

Tumor Immunotherapy

1.7K
Immunotherapy is a treatment that boosts or manipulates the immune system to fight diseases, including cancer. For instance, by stimulating an immune response through vaccinations against viruses that cause cancers, like hepatitis B virus and human papillomavirus, these diseases can be prevented. Nonetheless, some cancer cells can avoid the immune system due to their rapid mutation and division. The immune response to many cancers involves three phases: elimination, equilibrium, and escape.
1.7K
Asthma: Pathogenesis and Management01:20

Asthma: Pathogenesis and Management

1.2K
Asthma is a chronic pulmonary condition involving inflammation of the airways, hyper-reactivity, and reversible obstruction of the airways. This condition can significantly impact a person's quality of life, making breathing difficult and leading to distressing symptoms.
Asthma is classified as allergic and non-allergic. Allergens such as dust mites, pollen, and pet dander trigger allergic asthma, while factors like cold air, intense emotions, or exercise can induce non-allergic asthma.
1.2K
Drugs Used in Lower Respiratory Disorders: Overview01:17

Drugs Used in Lower Respiratory Disorders: Overview

1.0K
Lower respiratory tract disorders present challenges that often require skilled and nuanced approaches for effective management. Common ailments, such as asthma and chronic obstructive pulmonary disease (COPD), have prompted the development of intricate treatment strategies involving bronchodilators and anti-inflammatory drugs, each tailored to ease breathing and revitalize the lungs.
Bronchodilators, the first step of respiration enhancement, come in various forms, each with its own mechanism...
1.0K
Asthma-IV: Diagnostic and Management01:30

Asthma-IV: Diagnostic and Management

3.1K
The diagnosis and management of asthma are comprehensive, encompassing clinical assessments, lung function tests, and pharmacological interventions. Here's an overview:
Clinical Assessment for Asthma:
This is the first step in diagnosing and managing asthma. It includes:
3.1K
Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids01:25

Antiasthma Drugs: Inhaled Corticosteroids and Glucocorticoids

1.5K
Inhaled corticosteroids (ICS) are anti-inflammatory drugs used primarily in treating persistent asthma and providing long-term maintenance. They target the bronchial mucosa, the lining of the airways, to control inflammation, a critical factor in asthma progression and exacerbation.
ICS work through a multifaceted mechanism of action. They suppress the inflammatory response caused by the proliferation of TH cells. They also reduce the transcription of the IL-2 gene, which is involved in the...
1.5K

您也可能阅读

相关文章

通过共同作者、期刊和引用图与本文相关的文章。

排序
Same author

The Ste20 kinase TAOK3 restrains Rac-driven cytoskeletal-mitochondrial coupling to preserve naive CD8<sup>+</sup> T cell homeostasis and activation.

Frontiers in immunology·2026
Same author

Endothelial cells notch monocytes toward an alveolar macrophage fate.

The Journal of experimental medicine·2026
Same author

Multivalent Antibody-Recruiting Molecules for Targeted Immune-Killing of Carbonic Anhydrase IX-Expressing Cancer Cells.

Angewandte Chemie (International ed. in English)·2026
Same author

Marker-Agnostic Tumor Anchoring Chimeras Enable pH-Gated Immune Engagement.

Angewandte Chemie (International ed. in English)·2026
Same author

Protocol for mapping murine myeloid bone marrow progenitors and their differentiation into CD103<sup>+</sup> cDC1s and CD301b<sup>+</sup> cDC2s.

STAR protocols·2026
Same author

HIF-1α<sup>+</sup> CD4<sup>+</sup> T cells coordinate a tissue-resident immune cell network in the lung.

Immunity·2026
Same journal

FAM234A acts as a switch between Th17 and Treg cell fate decisions that control inflammatory bowel disease.

Cellular & molecular immunology·2026
Same journal

Targeting SPP1 requires moving beyond ligand blockade.

Cellular & molecular immunology·2026
Same journal

USP9X trims STAT1 to curb oncostatin M activity and intestinal inflammation.

Cellular & molecular immunology·2026
Same journal

Itaconate induces noncanonical AIM2-dependent PANoptosis in sepsis.

Cellular & molecular immunology·2026
Same journal

EZH2: an epigenetic governor of T-cell Ca<sup>2+</sup> homeostasis.

Cellular & molecular immunology·2026
Same journal

Vimentin trogocytosis as a novel mechanism of NK cell exhaustion by circulating tumor cells.

Cellular & molecular immunology·2026
查看所有相关文章

相关实验视频

Updated: Jan 14, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.4K

治疗喘的免疫疗法

Hamida Hammad1,2, Engi Ahmed3,4,5, Bart N Lambrecht3,4

  • 1Laboratory of Immunoregulation and Mucosal Immunology, VIB-UGent Center for Inflammation Research, Ghent, Belgium. hamida.hammad@ugent.be.

Cellular & molecular immunology
|October 28, 2025
PubMed
概括
此摘要是机器生成的。

2型高喘涉及Th2细胞和相关的细胞因子,导致常见的喘症状. 2型低喘的特点是中性粒细胞和不良的类固醇反应,需要针对性治疗以更好地治疗喘.

关键词:
喘 喘 是一种过敏原 过敏原 过敏原生物制剂. 生物制剂.终极类型 (Endotypes) 是一种内型.免疫疗法 免疫疗法

更多相关视频

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

5.0K
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

8.1K

相关实验视频

Last Updated: Jan 14, 2026

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma
14:39

Bronchial Thermoplasty: A Novel Therapeutic Approach to Severe Asthma

Published on: November 4, 2010

32.4K
A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion
05:56

A Traditional Chinese Medicine Characteristic Therapy for Bronchial Asthma: Moxibustion

Published on: May 12, 2023

5.0K
Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy
10:39

Advanced Imaging of Lung Homing Human Lymphocytes in an Experimental In Vivo Model of Allergic Inflammation Based on Light-sheet Microscopy

Published on: April 16, 2019

8.1K

科学领域:

  • 免疫学 免疫学 免疫学
  • 肺部病理学 肺部病理学
  • 过敏 过敏是一种过敏.

背景情况:

  • 2型高喘是最常见的形式,由T助手2 (Th2) 细胞和IL-4,IL-5和IL-13等细胞因子驱动.
  • 这些细胞因子有助于eosinophilia,IgE生产,支气管过敏反应,粘液过分分泌和恶化.
  • 2型低喘的特征是中性粒细胞和皮质类固醇反应的降低.

研究的目的:

  • 审查不同喘内型的基础免疫机制.
  • 提供当前喘免疫疗法及其临床疗效的概述.
  • 突出改善喘管理的新兴治疗策略.

主要方法:

  • 关于喘免疫机制的文献综述.
  • 分析当前免疫疗法选择及其有效性.
  • 探索新的和未来的喘治疗方法.

主要成果:

  • 详细解释Th2驱动的2型高喘病理生理学.
  • 2型低喘的特征,强调中性粒细胞的参与.
  • 鉴定特定的细胞因子及其在喘病原性中的作用.

结论:

  • 了解不同的喘内型对于开发有针对性的疗法至关重要.
  • 目前的免疫疗法提供了不同的疗效,这取决于喘的形状.
  • 新兴的策略有望在未来加强对各种喘表现的管理.